New hope for Tough-to-Treat uterine cancer?
NCT ID NCT07170982
Summary
This study is testing whether adding a new drug called fruquintinib to standard chemotherapy works better than chemotherapy alone for advanced endometrial cancer that has not spread to other organs. It will involve 128 women with this specific type of cancer who have not had prior treatment for their advanced disease. The main goal is to see if the combination helps shrink tumors more effectively and for a longer time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.